2017
DOI: 10.1097/eja.0000000000000614
|View full text |Cite
|
Sign up to set email alerts
|

Kinetics of plasma biomarkers of inflammation and lung injury in surgical patients with or without postoperative pulmonary complications

Abstract: The PROVHILO trial, including this substudy, was registered at clinicaltrials.gov (NCT01441791).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
19
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 34 publications
(23 citation statements)
references
References 29 publications
4
19
0
Order By: Relevance
“…This reinforces the hypothesis that volutrauma is more injurious than atelectrauma in non-obese rats. The absence of changes in mediators other than those associated with inflammation is consistent with post hoc analyses of the PROVHILO trial, in which high-PEEP leads to minimal changes in biological markers (Serpa Neto et al, 2017).…”
Section: Discussionsupporting
confidence: 79%
“…This reinforces the hypothesis that volutrauma is more injurious than atelectrauma in non-obese rats. The absence of changes in mediators other than those associated with inflammation is consistent with post hoc analyses of the PROVHILO trial, in which high-PEEP leads to minimal changes in biological markers (Serpa Neto et al, 2017).…”
Section: Discussionsupporting
confidence: 79%
“…It plays a role in attenuation of inflammatory responses and, consequently, a higher serum CC16 level is associated with better outcomes in patients with acute respiratory distress syndrome [ 32 ]. Furthermore, a rapid increase of serum CC16 has been reported after lung distention injury, possibly to elicit protective effects [ 10 , 33 ]. In this study, serum CC16 levels were significantly increased between the baseline (T 1 ) and 1 hour after resumption of two lung (T 2 ) in both groups.…”
Section: Discussionmentioning
confidence: 99%
“…However, none of the ILs reached a sufficient prognostic value. [ 11 ] Patients with pulmonary complications after esophagectomy showed increased levels of IL-6 and IL-10. [ 12 ] IL-6 was used as a predictive biomarker of systemic inflammatory response after non-cardiac thoracic surgery without analyzing a possible impact on postoperative complications.…”
Section: Introductionmentioning
confidence: 99%